Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on: December 28,2023

Possible new cancer treatment target discovered

byUniversity of GothenburgChandrasekhar Kanduri and Meena Kanduri, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg. Credit: Elin LindströmResearchers at the Univers

Updated on:December 28,2023

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec

Updated on: August 03,2024

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec

Updated on:August 03,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on: May 23,2024

Drug combo heralds major shift in chronic lymphocytic leukemia treatment

by Stanford University Medical CenterCancer cells. Credit: Dr. Cecil Fox, National Cancer InstituteA combination of two drugs keeps patients with chronic lymphocytic leukemia disease-free and ali

Updated on:May 23,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on: June 06,2024

Researchers probe microbiome-cancer treatment link

by Nathan Collins,Stanford UniversityCredit: CC0 Public DomainCancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immun

Updated on:June 06,2024

Non-invasive device more effective for early detection of lymphedema after breast cancer

byCleveland ClinicCredit: Cleveland ClinicSome breast cancer survivors may experience lymphedema, a condition that causes painful swelling of their arm or hand after undergoing surgery or radiat

Updated on: January 10,2024

Non-invasive device more effective for early detection of lymphedema after breast cancer

byCleveland ClinicCredit: Cleveland ClinicSome breast cancer survivors may experience lymphedema, a condition that causes painful swelling of their arm or hand after undergoing surgery or radiat

Updated on:January 10,2024

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm

Updated on: March 30,2024

In the fight against breast cancer, researchers identify malignancy hibernation as the next battleground

by University of Massachusetts AmherstTreatment approaches for breast cancer dormancy. Plausible therapeutic pathway targets to (A) directly kill, (B) maintain, or (C) activate and then kill dorm

Updated on:March 30,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on: July 05,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on:July 05,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on: November 09,2024

Study increases understanding of what makes multiple recurrent meningiomas the most aggressive form of brain tumor

by Graciela Gutierrez,Baylor College of MedicineWES reveals a greater burden of chromosomal losses in MRMs. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adn4419Researchers at B

Updated on:November 09,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on: January 23,2024

Genetically modified herpes virus delivers one-two punch against advanced cancers

byInstitute of Cancer ResearchCarcinoma of salivary gland. Credit: Nephron, CC BY-SA 4.0, via Wikimedia CommonsA new genetically engineered virus has delivered a one-two punch against advanced c

Updated on:January 23,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on: March 20,2024

Most survivors of childhood cancer don't get the tests needed to detect serious long-term adverse effects, finds study

by Canadian Medical Association JournalCredit: CC0 Public DomainSurviving childhood cancer does not always mean a clean bill of health, as the treatments that eradicate those cancers can put adul

Updated on:March 20,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on: February 23,2024

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Updated on:February 23,2024